Key Highlights

  • The Carlyle Group traded at US$37.80, against a consensus target of US$59.29.
  • The median target of US$63 implies roughly +66.7% upside from the current price.
  • Targets span US$43 to US$73, framing the range of analyst opinion.
  • The consensus implies +56.9% upside, reflecting the balance of current analyst views.

The Carlyle Group (NASDAQ:CG) traded at US$37.80 as of 8 October 2026, against an analyst consensus price target of US$59.29, an implied upside of approximately +56.9%.

What Is the Latest Analyst Price Target?

According to a data provider screener as at 8 October 2026, the mean analyst price target is $59.29, with a median of $63. That implies potential upside of 56.9% from the 8 October close. The range is wide, running from a low of $43 to a high of $73, a spread of $30 between the most cautious and most optimistic views. The median sitting above the mean hints that a few lower estimates are pulling the average down.

What Are Analysts Saying?

The provider's categorical consensus rating is Buy. so it would be wrong to read more into the rating than the figure itself offers. What the range does show is telling: even the lowest target of $43 sits above the current share price, meaning every target in the sample points to potential upside rather than downside. It is also worth remembering that a Buy label describes sentiment among those surveyed, not a measured probability of any outcome, and sentiment in alternative asset managers can swing quickly with Credit conditions.

What Could Help the Stock Reach the Price Target?

Carlyle has positioned itself as a global Investment firm spanning private equity, global credit and investment solutions. If analysts prove correct, the case rests on fee-related Earnings growing steadily as Assets under management expand, and on successful exits crystallising performance fees that have been delayed by a subdued deal environment. Falling interest rates would typically ease financing costs for buyouts and encourage more transactions. The shares also offer a trailing Dividend Yield of 3.6%, which some investors view as a cushion while they wait. Its global footprint and long-standing relationships with pension funds and sovereign investors give it distribution strength that smaller rivals struggle to match, and any pick-up in inflows would reinforce the growth narrative.

What Could Prevent the Stock Reaching the Target?

Realisation-driven businesses are inherently lumpy. Performance income depends on markets that allow profitable sales of portfolio companies, and a weak equity or credit backdrop can postpone those events for quarters. Fundraising is another pressure point, as competition among large alternative managers is intense and institutional allocators can be selective. Regulatory scrutiny of private markets and the sheer premium multiple implied by a P/E of 39.4 also leave less room for disappointment, and targets can lag if the share price moves quickly. Leadership transitions and strategic reshuffles at large alternative managers can also distract from execution, while the elevated earnings multiple means a modest earnings miss may be punished disproportionately.

What Should Investors Watch Next?

Investors will want to follow the next quarterly results and any guidance, paying particular attention to fundraising totals, deployment pace and realisation activity. Movements in interest rates and the broader IPO and M&A calendar are likely to shape the pace of exits. Management commentary on fee-related earnings and on the evolving mix of credit versus Private Equity could also prove informative, as could any updates on Capital returns. Because Carlyle reports distributable earnings alongside accounting profit, following both measures will help readers understand how much of the headline figure is recurring.

The Case Analysts Are Making on The Carlyle Group

The Carlyle Group (CG) was priced at US$37.80 against a consensus target of US$59.29, an implied upside of approximately +56.9%. The median target of US$63 and the range of US$43 to US$73 frame the debate among analysts.